JAK2 and acquired polycythemia vera: We used induced pluripotent stem cell (iPSC)-derived CD34+ progenitor-enriched cultures (CD34+ P-ECs) from a JAK2 V617F-positive PV patient and from a JAK2 wild-type healthy control [82].